EWM
ABBV icon

Elite Wealth Management’s AbbVie ABBV Stock Holding History

Elite Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50
Closed -$3K – 68
2014
Q3 		$3K Hold
50
– – ﹤0.01% 421
2014
Q2 		$3K Sell
50
-50
-50% -$2.62K ﹤0.01% 348
2014
Q1 		$5K Sell
100
-208
-68% -$10.5K ﹤0.01% 274
2013
Q4 		$16K Sell
308
-456
-60% -$22.4K 0.01% 302
2013
Q3 		$34K Sell
764
-174
-19% -$7.71K 0.03% 197
2013
Q2 		$39K Buy
+938
New +$41K 0.06% 139

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Elite Wealth Management's ABBV Position: Q4 2014 in Review

Elite Wealth Management sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 50 shares — an estimated $3K sold.

Elite Wealth Management first reported a position in ABBV in Q2 2013 and held it in 6 quarters. The position peaked at $39K in Q2 2013. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Elite Wealth Management reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
  • Elite Wealth Management sold 50 AbbVie shares in Q4 2014, an estimated $3K.
  • Elite Wealth Management first reported a position in AbbVie in Q2 2013 and held it in 6 quarters.
  • Elite Wealth Management's AbbVie position peaked at $39K in Q2 2013.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Elite Wealth Management's 13F filing for Q4 2014, filed 13 Oct 2016.